Literature DB >> 6313508

The effect of mouse hepatitis virus infection on the microcirculation of the liver.

G A Levy, P J MacPhee, L S Fung, M M Fisher, A M Rappaport.   

Abstract

Mouse hepatitis virus type 3 infection results in strain-dependent liver disease. The effects of mouse hepatitis virus type 3 on the microcirculation of the liver in both fully susceptible (Balb/cJ) and fully resistant (A/J) mice were studied. In Balb/cJ mice, 6 to 12 hr following infection, abnormalities in liver blood flow were observed which consisted of granular blood flow in both terminal hepatic and terminal portal venules. In addition, sinusoidal microthrombi were present predominantly in periportal areas. By 24 to 48 hr, liver cell edema and small focal lesions were prominent. At 48 hr, thrombi and hepatocellular necrosis were widespread, and blood was shunted from damaged areas into patent sinusoids. In sharp contrast to these abnormal findings, normal streamlined blood flow was present in the resistant A/J animals at all time points following infection. Since large amounts of virus were demonstrated by immunofluorescene in and by recovery and growth from livers of both resistant and susceptible strains, the presence of the virus per se cannot explain the abnormalities observed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313508      PMCID: PMC7165650          DOI: 10.1002/hep.1840030614

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  41 in total

1.  Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms.

Authors:  C Le Prevost; E Levy-Leblond; J L Virelizier; J M Dupuy
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

2.  EMC viral infection of the coronary blood vessels in newborn mice: viral vasculitis.

Authors:  G E Burch; P Rayburn
Journal:  Br J Exp Pathol       Date:  1977-10

Review 3.  The biology and pathogenesis of coronaviruses.

Authors:  H Wege; S Siddell; V ter Meulen
Journal:  Curr Top Microbiol Immunol       Date:  1982       Impact factor: 4.291

4.  A mechanism of migration inhibition in delayed-type hypersensitivity reactions. I. Fibrin deposition on the surface of elicited peritoneal macrophages on vivo.

Authors:  K E Hopper; C L Geczy; W A Davies
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

5.  Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro.

Authors:  G A Levy; B S Schwartz; L K Curtiss; T S Edgington
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

6.  Correlation of persistent mouse hepatitis virus (MHV-3) infection with its effect on mouse macrophage cultures.

Authors:  J L Virelizier; A C Allison
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

7.  Ultrastructural cytochemical studies of cerebral microvasculature in scrapie infected mice.

Authors:  A W Vorbrodt; A S Lossinsky; H M Wisniewski; R C Moretz; L Iwanowski
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

8.  Structural polypeptides of the murine coronavirus JHM.

Authors:  H Wege; H Wege; K Nagashima; V ter Meulen
Journal:  J Gen Virol       Date:  1979-01       Impact factor: 3.891

9.  Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. II. Adherent cell-mediated protection.

Authors:  S A Stohlman; J A Frelinger; L P Weiner
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

10.  Necrotizing vasculitis in a case of disseminated neonatal herpes simplex infection.

Authors:  P R Phinney; S Fligiel; Y J Bryson; D D Porter
Journal:  Arch Pathol Lab Med       Date:  1982-02       Impact factor: 5.534

View more
  20 in total

1.  Clinical significance of hepatic derangement in severe acute respiratory syndrome.

Authors:  Henry-Lik-Yuen Chan; Ambrose-Chi-Pong Kwan; Ka-Fai To; Sik-To Lai; Paul Kay-Sheung Chan; Wai-Keung Leung; Nelson Lee; Alan Wu; Joseph Jao-Yiu Sung
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

Review 2.  The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications.

Authors:  Jiemiao Hu; Jun Yan; Ganesh Rao; Khatri Latha; Willem W Overwijk; Amy B Heimberger; Shulin Li
Journal:  Int Rev Immunol       Date:  2014-09-26       Impact factor: 5.311

3.  Absence of monocyte procoagulant activity during the immune response to influenza virus.

Authors:  M Mathies; N Hogg
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

Review 4.  Fulminant hepatitis.

Authors:  S Sinclair; A Wakefield; G Levy
Journal:  Springer Semin Immunopathol       Date:  1990

Review 5.  Coronavirus pathogenesis.

Authors:  Susan R Weiss; Julian L Leibowitz
Journal:  Adv Virus Res       Date:  2011       Impact factor: 9.937

6.  The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.

Authors:  Philip A Marsden; Qin Ning; Laisum S Fung; Xioping Luo; Yue Chen; Michael Mendicino; Anand Ghanekar; Jeremy A Scott; Teresa Miller; Camie W Y Chan; Mathew W C Chan; Wei He; Reginald M Gorczynski; David R Grant; David A Clark; M James Phillips; Gary A Levy
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

7.  A Th1 cell line (3E9.1) from resistant A/J mice inhibits induction of macrophage procoagulant activity in vitro and protects against MHV-3 mortality in vivo.

Authors:  S Chung; R Gorczynski; B Cruz; R Fingerote; E Skamene; S Perlman; J Leibowitz; L Fung; M Flowers; G Levy
Journal:  Immunology       Date:  1994-11       Impact factor: 7.397

8.  Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity.

Authors:  R L Parr; L Fung; J Reneker; N Myers-Mason; J L Leibowitz; G Levy
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis.

Authors:  G A Levy; M Liu; J Ding; S Yuwaraj; J Leibowitz; P A Marsden; Q Ning; A Kovalinka; M J Phillips
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

10.  The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection.

Authors:  Itay Shalev; Nazia Selzner; Ahmed Helmy; Katharina Foerster; Oyedele A Adeyi; David R Grant; Gary Levy
Journal:  Rambam Maimonides Med J       Date:  2010-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.